Does Skin Tone Affect Efficacy of Therapy for Atopic Dermatitis? Probably Not
AAD 2025: Raj Chovatiya, MD, PhD, MSCI, well-known physician scientist, says underrepresentation in clinical trials of those with skin of color precludes an evidence-based answer.
Early Amyloid Plaque Removal May Delay Alzheimer Disease Onset, A First-of-Its-Kind Study Suggests
In a small study of adults genetically predisposed to early-onset dementia, anti-amyloid treatment to remove plaque reduced risk of developing symptoms by 50%.
Study: 72% of Asymptomatic UTI Patients Receive Unnecessary Antibiotics
Researchers recommend expanding antimicrobial stewardship efforts to better track and reduce unnecessary antibiotic use.
Millions of US Adults Have Multiple Forms of Eczema, Study Finds
Nearly 1 in 10 US adults have eczema, with 18% experiencing multiple eczema conditions, researchers from the National Eczema Association reported.
The 10 States with the Highest Risk for Cancer
The greatest risk for developing cancer faces residents of South Dakota, where radon levels are the nation's highest, and ranks for alcohol consumption and obesity are poor.
Guselkumab (Tremfya) Wins Approval for Crohn Disease, Fourth Indication for Immune-Mediated Diseases
The IL-23 inhibitor is the only drug in the class available with both subcutaneous and intravenous administration options for treatment induction, according to J&J.
Investigational Keto Diet Pill Shows Promise in Phase 1 Trial: Daily Dose
Your daily dose of the clinical news you may have missed.
The Exposome is Everything in Atopic Dermatitis: An Expert Perspective on AD Pathophysiology
Raj Chovatiya, MD, PhD, MSCI, discusses the complex and widely variable influences that affect the manifestations and burden of atopic dermatitis across populations.
Universal ED Syphilis Screening Outperforms Targeted Approaches, Study Shows
CROI 2025: Researchers reported that a universal syphilis screening program identified more cases than programs targeting specific patient populations.
AGA: AI-Assisted Colonoscopy Increases Adenoma Detection, But Long-Term Benefits Unclear
New AGA guidelines conclude that it is not clear whether computer-aided detection systems for colonoscopy should be recommended for routine widespread use.
Melanin Isn't Everything: Skin Physiology Does Not Conform to Socially Defined Variables, Explains Raj Chovatiya, MD, PhD, MSCI
AAD 2025: Chovatiya discusses whether melanin concentration plays a role in skin physiology and cautioned against typing with factors that are not true biologic constructs.
Dupilumab Found Beneficial in COPD with Type 2 Inflammation: Daily Dose
Improved HPV Vaccination Coverage May Help Prevent Noncervical Cancers in People with HIV
CROI 2025: Increased HPV vaccine coverage could reduce HIV cases by thousands, according to a new study.
US Adult Vaccination Snapshots: Current Coverage, Trends, and Concerns
Get the latest immunization updates, data on racial disparities, and practical guidance for clinical practice, here.
Massive Trump Administration Cuts to Federal Grants Halt National Diabetes Prevention Program
The 30-year program has tracked and compiled data on diabetes prevention, treatment, and outcomes, providing a foundation and insights for international research.
ZUPREME-1 Phase 2b Trial of Petrelentide for Obesity Completes Enrollment
The amylin analog at 5 doses will be compared with placebo when added to a reduced calorie diet and increased physical activity regimen for 42 weeks, said Zealand Pharma.
Roflumilast Cream Shows Strong Tolerability in Patients with AD Failing Other Topicals: Daily Dose
What We Mean When We Say "Skin of Color" in Dermatology: A Closer Look with Raj Chovatiya, MD, PhD, MSCI
Chovatiya, expert clinical dermatologist and researcher, points out that the term "skin of color" comprises a heterogenous set of topics, in an interview at AAD 2025.
Managing Atopic Dermatitis in Special Populations: Expert Insights for Primary Care
In an interview at AAD 2025, Katrina Abuabara, MD, stressed the importance of collaboration between primary care physicians and dermatologists.
Antibiotics, NSAIDs Reported Most Common Cause of Pediatric Anaphylaxis
Among pediatric patients aged 1 month to 18 years with emergent anaphylaxis, cephalosporins were the leading antibiotics and ibuprofen the top NSAID implicated in a new study.
.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Millions of US Adults Have Multiple Forms of Eczema, Study Finds")
